Pfizer Is Available For Purchase

  Pfizer Is Available For Purchase This investment offers investors a good mix of value and growth.   Buying stakes (aka FAANG) in top tech stocks Facebook FB (NASDAQ) $355,64 0,00 (%0,00) Apple, Amazon, Netflix, and Alphabet (Google) has yielded big gains in the past. But now, the cheapest of these stocks (Apple and Facebook) is trading at a price-to-earnings (P/E) of over 26 despite valuations rising. This does not seem that attractive when compared to other growth. It's time to get the most out of your investment dollar. In this case, it is necessary to consider buying Pfizer (NYSE:PFE) shares instead of FAANG. Currently the Company has Strong, Growing earnings and can be purchased much cheaper.

Pfizer

That's why healthcare giant Pfizer PFE (NYSE) $39,25 +0,13 (+%0,33) is trading at just 10x its future earnings. The company has shrunk recently, but has now become more growth-oriented to form Viatris after the November 2020 split of the Mylan and Upjohn business.

This investment offers investors a good mix of value and growth.

For the period ended September 27, Pfizer continued its quarterly revenue of $1.9 billion, down 19% year-over-year. And thanks to its COVID-19 vaccine, Pfizer is on a great path. The pharmaceutical giant is expected to generate sales of $26 billion from this year's vaccine and its revenue is estimated to be between $70.5 billion and $72.5 billion. However, its revenue in 2020 was just under 42 billion. Although investors may be concerned that vaccine sales will be short-lived, the World Health Organization argues that many vulnerable people may need booster vaccines on an annual basis. Also, Pfizer is currently working on an oral medication for COVID-19 that people can take at home to make it even easier. The drug is expected to be ready before the end of the year if trials work well. With strong vaccine sales, focus on developing new drugs and being a leaner organization, Pfizer has become a more attractive growth stock  

Source: The Motley Fool

 

You may also be interested in:

 

JP Morgan Strategists Commented On The Cryptocurrency Market